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ABSTRACT Ribosome assembly is an essential process that consumes prodigious quantities 
of cellular resources. Ribosomal proteins cannot be overproduced in Saccharomyces cerevi-
siae because the excess proteins are rapidly degraded. However, the responsible quality 
control (QC) mechanisms remain poorly characterized. Here we demonstrate that overex-
pression of multiple proteins of the small and large yeast ribosomal subunits is suppressed. 
Rpl26 overexpressed from a plasmid can be detected in the nucleolus and nucleoplasm, but 
it largely fails to assemble into ribosomes and is rapidly degraded. However, if the endoge-
nous RPL26 loci are deleted, plasmid-encoded Rpl26 assembles into ribosomes and localizes 
to the cytosol. Chemical and genetic perturbation studies indicate that overexpressed ribo-
somal proteins are degraded by the ubiquitin–proteasome system and not by autophagy. 
Inhibition of the proteasome led to accumulation of multiple endogenous ribosomal proteins 
in insoluble aggregates, consistent with the operation of this QC mechanism in the absence 
of ribosomal protein overexpression. Our studies reveal that ribosomal proteins that fail to 
assemble into ribosomes are rapidly distinguished from their assembled counterparts and 
ubiquitinated and degraded within the nuclear compartment.
INTRODUCTION
Protein quality control (PQC) is critical for maintenance of protein 
homeostasis in eukaryotic cells. PQC pathways specific for multiple 
cellular compartments have been identified, including ones dedi-
cated to misfolded proteins in the cytosol (Eisele and Wolf, 2008; 
Heck et al., 2010; Nillegoda et al., 2010), nucleus (Gardner et al., 
2005), plasma membrane (Zhao et al., 2013), and endoplasmic re-
ticulum membrane (Vembar and Brodsky, 2008). Indeed, there even 
exist PQC pathways that attack defective translation products as 
they emerge from the ribosome (Bengtson and Joazeiro, 2010; 
Brandman et al., 2012; Defenouillere et al., 2013; Verma et al., 
2013). However, given the enormous diversity of protein structure 
and localization, it is likely that our understanding of PQC is far from 
complete.
In surveying the landscape of challenges facing protein biogen-
esis, we alighted on the ribosome as an interesting target for the 
mechanistic investigation of PQC. Ribosome formation in yeast is a 
complicated process that requires transcription of 35S and 5S 
rRNAs, processing of 35S primary rRNA, translation and nuclear im-
port of 79 different ribosomal proteins, and assembly of processed 
rRNAs and ribosomal proteins in the nucleolus (Kressler et al., 2010). 
Ribosome assembly is not only complex, but it also monopolizes an 
impressive fraction of biogenic capacity. In rapidly growing yeast 
cells, 60% of total transcription is devoted to rRNA, and 50% of RNA 
polymerase II transcription and 90% of mRNA splicing are devoted 
to ribosomal proteins (Warner, 1999). This tremendous flux places a 
premium on efficient PQC mechanisms to minimize formation and 
accumulation of unusable components. However, despite a rapid 
expansion in our understanding of homeostatic regulatory mecha-
nisms for assembled ribosomes, the homeostatic mechanisms that 
monitor ribosome assembly and help cells cope with errors or im-
balances in the assembly process remain poorly understood.
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pressed from the same GAL1 promoter (Figure 1, B, quantified and 
shown as black bars in C). This result extends support for the hy-
pothesis that although ribosomal proteins are generally believed to 
be stable, those made in excess are culled by an unknown QC 
mechanism.
If the foregoing hypothesis is correct, we predicted that disrup-
tion of the chromosomal copies of a plasmid-borne ribosomal gene 
would restore stoichiometric balance and allow accumulation of the 
induced, plasmid-encoded protein (Figure 2A). To test this predic-
tion and more generally to study the fate of excess ribosomal pro-
teins, we focused on Rpl26 because 1) the steady-state level of ec-
topically expressed Rpl26a-HHZ in WT was low (Figure 1, B and C), 
2) rpl26a∆rpl26b∆ double mutants are viable (Babiano et al., 2012; 
Supplemental Figure S1A) and exhibited only a modest defect in 
One simple but profound question about ribosome assembly 
concerns how the cell controls ribosomal gene expression to en-
sure stoichiometric production of all proteins. Several studies have 
suggested that some ribosomal proteins may be made in excess, 
and the cell maintains an appropriate level of these proteins by 
degrading the unassembled ones. The existence of such a mecha-
nism is supported by several lines of evidence. For example, newly 
synthesized ribosomal proteins are rapidly degraded when rRNA 
processing is impaired (Gorenstein and Warner, 1977; Warner, 
1977). In addition, in cells harboring extra copies of a ribosomal 
protein gene, overproduction of the corresponding protein cannot 
be detected unless extremely short pulse labeling (∼45 s) is per-
formed (Abovich et al., 1985). Based on these observations, it was 
proposed that some ribosomal proteins are normally synthesized 
at levels beyond what cells require, but the excess amounts are 
degraded rapidly, such that they do not detectably accumulate. 
However, the mechanism by which the overproduced ribosomal 
proteins are degraded was not explored. This hypothesis is sup-
ported by two more recent studies. Experiments with pulsed stable 
isotope labeling with amino acids in cell culture demonstrate that 
newly synthesized human ribosomal proteins are rapidly imported 
into the nucleolus for assembly with rRNA and the excess is de-
graded by the proteasome (Lam et al., 2007). Furthermore, whereas 
acquisition of an extra chromosome in yeast leads to proportional 
increases in mRNA and protein levels for most of the genes on the 
extra chromosome (Torres et al., 2007, 2010), most ribosomal pro-
teins do not increase proportionally with copy number but are at-
tenuated posttranslationally by an unidentified mechanism 
(Dephoure et al., 2014). Multiple mechanisms could potentially me-
diate degradation of excess ribosomal proteins. Whereas the hu-
man studies implicate the proteasome, it was not determined 
whether the degradation of ribosomal subunits observed by Lam 
et al. (2007) was related to assembly status or dependent on ubiq-
uitination. In yeast cells, two other mechanisms have been con-
nected to ribosome metabolism. Yeast cells starved of amino acids 
encapsulate existing mature ribosomes in autophagosomes in a 
process referred to as ribophagy (Kraft et al., 2008). In addition, 
yeast cells subject to heat shock form stress granules that contain 
40S subunits, and these are also eliminated by autophagy (Grousl 
et al., 2009).
In this study, we investigate the fate of ribosomal proteins that 
are made in stoichiometric excess over other ribosomal subunits. 
We demonstrate that overproduced ribosomal proteins largely fail 
to assemble into ribosomes and instead are rapidly ubiquitinated 
and degraded in the nucleus in a proteasome-dependent manner.
RESULTS
Ribosomal proteins produced in excess do not accumulate 
and are degraded by the ubiquitin–proteasome system
To investigate how unassembled ribosomal proteins are regulated, 
we first confirmed that overexpressed ribosomal proteins accumu-
late poorly, by measuring steady-state levels of several ribosomal 
proteins marked with a compound hexahistidine-hemagglutinin 
(HA)-protein A ZZ domain (hereafter referred as HHZ) epitope tag 
and transiently expressed from the GAL1 promoter in wild-type 
(WT) cells after a short induction with galactose (Figure 1A). For this 
and other experiments, we grew cells carrying a GAL-driven con-
struct on a 2-μm plasmid in raffinose-containing medium and in-
duced expression from the GAL promoter with 2% galactose for 
60–90 min before we harvested cells for analysis. Accumulation of 
ectopically overexpressed ribosomal proteins was lower than of the 
nonribosomal protein Hog1 even though all proteins were ex-
FIGURE 1: Overexpression of ribosomal proteins is inefficient.  
(A) Experimental scheme to evaluate overexpression of HHZ-tagged 
ribosomal proteins. (B) Steady-state levels of ribosomal proteins are 
lower than that of the nonribosomal protein Hog1 when all proteins 
are transiently overexpressed from the GAL promoter. Total cell 
lysates were fractionated by SDS–PAGE and immunoblotted 
with HA antibody. Hexokinase was used as an internal control. 
(C) Quantification of HHZ-tagged proteins in B. Relative HHZ-tagged 
protein levels were normalized to Hog1 using Odyssey software. 
Values are the mean of two independent experiments, and error bars 
indicate SDs.
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selective degradation of ribosomal proteins 
upon starvation is mediated by autophagy 
(Kraft et al., 2008). Suppression of Rpl26a-
FLAG overexpression remained intact in 
mutants defective in autophagy (atg7∆) or 
in degradation of proteins that enter the 
vacuole (pep4∆; Figure 3A). On the basis of 
this result, we next sought to test whether 
the UPS was involved. Addition of the pro-
teasome inhibitor bortezomib (btz) to cells 
overexpressing ribosomal proteins from the 
GAL10 promoter resulted in stronger accu-
mulation for Rpl26a-FLAG (Figure 3A) and 
seven of eight other ribosomal proteins 
tested (Figure 3, B–D). To test whether inhi-
bition of the proteasome caused the over-
expressed Rpl26a-FLAG to accumulate as 
ubiquitin-conjugated species, we affinity-
purified total cellular ubiquitin conjugated 
proteins from galactose-induced cells on 
ubiquitin-binding UBA domain resin and 
immunoblotted them with anti-FLAG anti-
body, which revealed that high–molecular 
weight (MW) forms of Rpl26a-FLAG accu-
mulated in the presence of proteasome in-
hibitor (Figure 4A) and in a pre9∆ mutant 
lacking the nonessential α3 subunit of the 
20S proteasome (Figure 4B) but not in 
pre9∆ cells that also lacked the endoge-
nous RPL26A and RPL26B (Figure 4C). To 
establish unambiguously that the accumu-
lated high-MW species were ubiquitin con-
jugates, we digested UBA resin eluates with 
deubiquitinating enzyme Usp2 before im-
munoblotting, which caused progressive, 
time-dependent loss of the high-MW spe-
cies and an increase in unmodified Rpl26a-
FLAG (Figure 4D). Finally, we showed that 
Rpl26a-FLAG immunoprecipitated from 
btz-treated cells under denaturing condi-
tions reacted with anti-ubiquitin antibody 
(Figure 4E). Taken together, our results 
demonstrate that excess ribosomal proteins 
are ubiquitinated and then degraded by 
proteasome.
Rpl26 produced in excess largely does not assemble into 
ribosomes but is ubiquitinated and then degraded by the 
proteasome
In general, ribosomal proteins are stable. For instance, a proteome-
wide study of protein degradation rates in Saccharomyces cerevi-
siae revealed that the median t1/2 for 85 TAP-tagged ribosomal pro-
teins is 144 min, which is longer than the doubling time (Belle et al., 
2006). However, an overproduced ribosomal protein would be in 
excess over its rRNA and protein partners and thus presumably 
would fail to assemble and be subject to degradation. To test this 
prediction, we used sucrose gradients to monitor the assembly of 
transiently overexpressed Rpl26a into ribosomes in WT and 
rpl26a∆rpl26b∆ cells. Transiently overexpressed Rpl26a-FLAG 
(Figure 5A), Rpl26a-GFP (Figure 5B), or Rpl26a-HHZ (Figure 5C) ef-
ficiently assembled into ribosomes in rpl26a∆rpl26b∆ cells but not 
in cells that constitutively expressed endogenous Rpl26. Of note, a 
polysome formation (Supplemental Figure S1B), and 3) interactions 
of Rpl26 with 5.8S and 25S rRNAs are characterized (Ben-Shem 
et al., 2011; Supplemental Figure S1C). Consistent with the QC hy-
pothesis, Rpl26a–green fluorescent protein (GFP; Figure 2B) or 
Rpl26a-FLAG (Figure 2C) expressed from the GAL10 promoter ac-
cumulated poorly upon transient induction in WT cells but exhibited 
robust accumulation in rpl26a∆rpl26b∆ cells. Moreover, the accu-
mulation of GAL10-driven Rpl26a-Flag was inversely proportional to 
the level of Rpl26-GFP constitutively expressed from a chromosomal 
locus (Figure 2D). Finally, the striking difference in GAL10-driven 
Rpl26a-GFP accumulation in WT versus rpl26a∆rpl26b∆ cells was 
not due to differences in mRNA expression (Figure 2E).
We next sought to identify the mechanism by which accumula-
tion of excess ribosomal protein was repressed. We first examined 
whether degradation of excess ribosomal proteins was regulated 
by ribosome autophagy (ribophagy), based on the observation that 
FIGURE 2: Overexpressed Rpl26a does not accumulate. (A) Experimental design. Ribosomal 
proteins synthesized in the cytoplasm are imported into the nucleolus for assembly with rRNA. 
In WT cells, excessive ribosomal protein transiently expressed from a plasmid (black circle) 
assembles poorly with rRNA because of competition from its preexisting endogenous 
counterpart (blue circle) and consequently becomes a substrate of a quality control mechanism. 
In mutant cells lacking chromosomal ribosomal protein genes corresponding to the plasmid-
borne gene, plasmid-encoded ribosomal protein (black circle) is successfully assembled with 
rRNA and is thereby stabilized and accumulates. (B, C) Endogenous Rpl26 restricts accumulation 
of induced Rpl26a. WT or rpl26a∆rpl26b∆ cells were induced with galactose for 1 h to express 
Rpl26a-GFP (B) or Rpl26a-FLAG (C), and cell lysates were fractionated by SDS–PAGE. 
Immunoblotting was performed using an antibody against GFP or FLAG. Hexokinase was used 
as an internal control. (D) Overexpressed Rpl26a-FLAG accumulation is reciprocal to the level of 
endogenous Rpl26-GFP. Cells of the indicated genotypes were induced with galactose for 1 h to 
express Rpl26a-FLAG. Cell lysate was fractionated by SDS–PAGE and immunoblotted with GFP 
and FLAG antibodies. Hexokinase was used as an internal control. (E) Poor induction of 
Rpl26a-GFP in WT is not due to reduced mRNA level. Total RNA was extracted from WT and 
rpl26a∆rpl26b∆ cells induced or not with galactose for 1 h, and RPL26A-GFP mRNA was 
measured by qPCR. ACT1 mRNA was used for normalization. Values are the mean of three 
independent experiments, and error bars indicate SDs.
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population of molecules was modified with 
ubiquitin, lysate from cells overexpressing 
Rpl26a-FLAG in the presence of bortezomib 
were fractionated on a sucrose gradient, 
and the unassembled, 40S/60S/80S, and 
polysome fractions were pooled separately 
and adsorbed to a UBA resin that binds 
polyubiquitin conjugates. The same proce-
dure was also carried out in parallel with 
cells containing empty vector. Bound pro-
teins were then evaluated by immunoblot-
ting with FLAG antibody. Strikingly, the 
ubiquitin-conjugated species of Rpl26a-
FLAG were exclusively found in the unas-
sembled fraction (Figure 5E). Taken to-
gether, these data indicate that the 
ubiquitination and degradation pathways 
are exquisitely specific for unassembled 
forms of Rpl26a.
The small steady-state pool of excess 
Rpl26 resides primarily in the nucleus 
and nucleolus
The observed ubiquitination and degrada-
tion of unassembled Rpl26a raised the 
question of where this process occurred. In 
proteasome-deficient pre9∆ cells, the ma-
jority of transiently overexpressed Rpl26a-
GFP accumulated in the nucleus, as judged 
by subcellular fractionation (Figure 6A). 
Both unmodified and ubiquitin-conjugated 
species were readily detected in the nuclear 
fraction, indicating that ubiquitination of ex-
cess unassembled Rpl26a occurred in the 
nuclear compartment. A similar result was 
obtained when degradation of excess 
Rpl26a-GFP was blocked by addition of the 
proteasome inhibitor MG132 (Figure 6B). 
Further, fluorescence microscopy revealed 
that Rpl26a-GFP fluorescence was confined 
to the nucleus in both WT and pre9∆ cells 
but was more intense and more frequently 
detected in the mutant cells (Figure 6C), 
consistent with the subcellular fractionation 
data in Figure 5, A and B. Of interest, the 
most intense focus of GFP staining in WT 
cells coincided with the nucleolar marker 
Nop56–monomeric red fluorescent protein (mRFP; Figure 6, C and 
D). Given this evidence that overproduced Rpl26a was most likely 
degraded in the nucleus, we tested whether its degradation de-
pended on the nuclear quality control ubiquitin ligase San1. How-
ever, overproduced Rpl26a-FLAG did not accumulate in san1∆ 
(Supplemental Figure S2), suggesting that some other PQC path-
way is involved. Of note, in some pre9∆ cells, the focus of GFP stain-
ing was distinct from the nucleolus (Figure 6C, bottom right, white 
arrow). This suggests that if degradation of Rpl26a-GFP is blocked 
by the pre9∆ mutation, some of the protein begins to aggregate in 
the nucleoplasm. These structures may correspond to the recently 
described intranuclear quality control compartment (Miller et al., 
2015). In contrast with WT cells, GAL10-driven Rpl26a-GFP was pri-
marily cytosolic in rpl26a∆rpl26b∆ cells (Figure 6D), in agreement 
with the observation that it efficiently assembled into ribosomes in 
substantial fraction of the induced FLAG- and GFP-tagged Rpl26a 
that was detectable was found in the low-MW unassembled fraction 
in WT but not rpl26a∆rpl26b∆ cells (Figure 5, A and B). The Rpl26a 
detected in the low-MW region of the gradients migrated more rap-
idly than the input and assembled Rpl26a upon SDS–PAGE, sug-
gesting that it was processed. We do not know the nature of this 
modification, but presumably the C-terminus remains intact be-
cause the processed protein reacts with antibodies to the C-termi-
nal tags. Presumably, this processing occurs in vitro, because we did 
not observe substantial amount of processed protein in total cell 
lysates prepared under denaturing conditions (Figure 2, B–D). Of 
importance, when cells transiently overexpressed Rpl26a-FLAG in 
the presence of bortezomib, there was a tremendous increase in the 
unassembled pool but only a very modest increase in the amount 
incorporated into ribosomes (Figure 5D). To determine which 
FIGURE 3: Excess ribosomal proteins are degraded by the proteasome. (A) Degradation of 
excess Rpl26a is not mediated by autophagy but by UPS. Cells were induced with galactose for 
1 h to express Rpl26a-FLAG. For proteasome inhibition, cells induced 30 min with galactose to 
express Rpl26a-FLAG were treated with 50 μM btz for an additional 30 min. Left, cell lysate was 
fractionated by SDS–PAGE and immunoblotted with FLAG antibody. Hexokinase was used as 
an internal control. Right, relative protein levels were normalized to –btz using Odyssey 
software. Values are the mean of two independent experiments, and error bars indicate SDs. 
(B) Experimental scheme to evaluate accumulation of HHZ-tagged ribosomal proteins upon 
proteasome inhibition. (C) Degradation of transiently overexpressed ribosomal proteins is 
mediated by proteasome. Cells were treated as depicted in B, and cell lysates were fractionated 
by SDS–PAGE and immunoblotted with HA antibody. Hexokinase was used as an internal 
control. (D) Quantification of HHZ-tagged proteins in C. The relative btz-treated, HHZ-tagged 
protein levels were normalized to mock-treated ones using Odyssey software. Values are the 
mean of two independent experiments, and error bars indicate SDs.
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semble into ribosomes. However, the great 
majority remains unassembled and is conju-
gated with ubiquitin and then degraded by 
the proteasome, most likely within the nu-
cleolar and/or nuclear compartments.
Newly synthesized endogenous 
ribosomal proteins aggregate in 
proteasome inhibitor–treated cells
Our observations showing UPS-mediated 
degradation of overexpressed ribosomal 
proteins raised the question of whether a 
similar mechanism operates on endogenous 
ribosomal proteins that fail to assemble. To 
address it, we treated cells with a protea-
some inhibitor to block degradation of any 
ribosomal proteins that fail to assemble, 
prepared soluble and insoluble cell lysate 
fractions, and evaluated them for their con-
tent of ribosomal proteins. Immunoblotting 
with several antibodies against ribosomal 
proteins (Rpl3 and Rps2) revealed that inhi-
bition of proteasome does not affect the 
level of ribosomal proteins in total and solu-
ble fractions (Figure 7A, shown in total and 
soluble). In contrast, the insoluble fraction 
from btz-treated cells contained significantly 
increased amounts of ubiquitin conjugates 
and ribosomal proteins compared with that 
of nontreated cells (Figure 7A, shown in pel-
let). We also observed that insoluble pro-
teins accumulated in pre9∆- and MG132-
treated cells (Supplemental Figure S3A), 
suggesting that this is a general response to 
proteasome inhibition and not an off-target 
effect of btz.
On the basis of the foregoing results, we 
sought to investigate more globally the effect 
of proteasome inhibition on accumulation of 
insoluble ribosomal proteins. To do this, we 
identified proteins recovered from pellet frac-
tions by mass spectrometry (MS) and esti-
mated their abundances by label-free abso-
lute quantification with intensity-based 
absolute quantification (iBAQ) as previously 
described (Geiger et al., 2012). Comparison 
of three biological replicates confirmed ex-
cellent reproducibility (Figure 7B and Supple-
mental Figure S3B). For all three biological 
replicates, a general trend of increasing pro-
tein accumulation in the insoluble fraction 
was observed upon proteasome inhibition, 
consistent with Coomassie blue staining 
(Figure 7A). Of note, the insoluble proteins 
with the largest increase in btz-treated cells 
over nontreated cells (NC) were ribosomal 
proteins of the large and small subunits in-
cluding Rpl3 and Rps2 (Figure 7B, Supple-
mental Figure S3C, and Supplemental Table S3). Gene ontology 
analysis of the MS data confirmed that ribosomal proteins from both 
subunits comprise the major class of aggregators upon proteasome 
inhibition (Figure 7C and Supplemental Figure S3D). This is clearly 
this genotype (Figure 5B). Taken together, our data suggest that 
upon overexpression, Rpl26 translocates to the nucleus and nucleo-
lus, where a small fraction of the overproduced protein outcom-
petes its endogenous, constitutively expressed counterpart to as-
FIGURE 4: Excess Rpl26a is ubiquitinated and then degraded by the proteasome. (A) Excess 
Rpl26a accumulates in polyubiquitinated forms after treatment with proteasome inhibitor. Cells 
induced 45 min with galactose to express Rpl26a-FLAG were treated with 50 μM btz for an 
additional 45 min. Total cell extract was adsorbed to UBA resin to enrich ubiquitin conjugates, 
and the bound fraction was separated by SDS–PAGE and immunoblotted with antibodies 
against FLAG and ubiquitin. Hexokinase was used as an internal control. (B) Excess Rpl26a 
is polyubiquitinated in a mutant lacking the α3 subunit of the 20S proteasome (pre9∆). 
Same as A except that pre9∆ cells were used and btz was omitted. (C) Rpl26a induced in 
pre9∆rpl26a∆rpl26b∆ is not polyubiquitinated. Same as B except that cells of different 
genotypes were used as indicated. (D) Usp2 deconjugates ubiquitin from Rpl26a. Cells induced 
for 45 min with galactose to express Rpl26a-FLAG were treated with 50 μM btz for an additional 
45 min. Total cell extract was adsorbed to UBA resin, and then ubiquitin conjugates collected 
by UBA resin were treated with or without Usp2 (1 μM) for indicated times and immunoblotted 
with antibodies against FLAG and ubiquitin. (E) Cells with or without the Rpl26a-FLAG plasmid 
and deleted for the multidrug exporter PDR5 were supplemented with 50 μM btz after 45 min 
of galactose induction. After an additional 45 min, total cell extract prepared under denaturing 
conditions was incubated with FLAG resin. The bound fraction was separated by SDS–PAGE and 
immunoblotted with an antibody against ubiquitin. Hexokinase was used as an internal control.
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of insoluble forms of the endogenous ribo-
somal proteins Rpl3 was clearly impaired 
when cells were cotreated with cyclohexi-
mide (Figure 7E), suggesting that the major 
source of aggregated ribosomal proteins 
was derived from newly synthesized proteins 
and not preexisting ribosomes.
DISCUSSION
Nearly 40 years ago, it was shown that when 
expression of rRNA is extinguished in either 
yeast or HeLa cells, synthesis of ribosomal 
proteins continues, but the unassembled 
proteins are rapidly degraded (Gorenstein 
and Warner, 1977; Warner, 1977). Subse-
quent work indicated that single ribosomal 
proteins cannot be stably overexpressed in 
yeast because the excess protein is de-
graded with exceptional speed after its syn-
thesis (Abovich et al., 1985; Warner et al., 
1985). However, pathways responsible for 
degradation of ribosomal proteins were not 
identified and largely escaped attention un-
til several years ago, when it was shown that 
ribosomal proteins are among the most 
prominent ubiquitin-conjugated species 
that accumulate upon inhibition of the pro-
teasome (Mayor et al., 2005, 2007) and that 
newly synthesized ribosomal proteins are 
rapidly turned over by the proteasome in 
the nucleolus of human cells (Lam et al., 
2007). Other important clues have emerged 
more recently, including the observation 
that an unknown posttranslational compen-
satory mechanism restricts accumulation of 
ribosomal proteins encoded on supernu-
merary chromosomes in aneuploid yeast 
cells (Dephoure et al., 2014).
Given the extraordinary level of re-
sources that eukaryotic cells commit to ribo-
some production (Warner, 1999), we rea-
soned that the pathway that degrades 
unassembled or misassembled ribosomal 
proteins could be one of the most important 
QC pathways in eukaryotes. Accordingly, 
we set out to characterize the basic features 
of this pathway. We show here that overex-
pressed ribosomal proteins of both the 
large and small subunits are degraded by 
the UPS and not by the autophagy pathway 
that degrades ribosomes in starved cells. 
Our data indicate that unassembled ribosomal proteins are largely 
confined to the nucleus, where they accumulate as ubiquitin-conju-
gated species upon chemical or genetic inhibition of the protea-
some. This distinguishes the ubiquitination pathway involved in 
marking excess ribosomal proteins from a recently described path-
way that ubiquitinates ribosomal proteins in response to endoplas-
mic reticulum stress (Higgins et al., 2015). In that case, ubiquitina-
tion selectively occurs in the cytoplasm on proteins that are 
assembled into 40S subunits.
We propose that degradation of unassembled ribosomal pro-
teins is constantly occurring in wild-type cells. It seems inescapable 
evident from a table of ∆iBAQ values for ribosomal proteins versus 
nonribosomal proteins (Supplemental Table S4) and a plot of the top 
20 aggregate-prone proteins in the presence of proteasome inhibitor 
(Figure 7D).
To further explore whether aggregated ribosomal proteins were 
produced from existing mature ribosomal proteins or were newly syn-
thesized, we analyzed pellet fractions from cells treated with btz in the 
presence or absence of the protein synthesis inhibitor cycloheximide. 
Coomassie blue staining revealed that cycloheximide treatment sig-
nificantly suppressed accumulation of insoluble proteins in btz-
treated cells (Figure 7E). Of importance, btz-dependent accumulation 
FIGURE 5: Rpl26 produced in excess largely does not assemble into ribosomes but is 
ubiquitinated and then degraded by the proteasome. (A, B) Rpl26a produced in excess poorly 
assembles into ribosomes. WT and rpl26a∆rpl26b∆ cells were induced with galactose for 1 h to 
express Rpl26a-FLAG (A) or Rpl26a-GFP (B) and then treated with cycloheximide for 15 min 
before cell lysis to stabilize polysomes. Cell lysate was fractionated on a sucrose gradient, and 
fractions were analyzed by SDS–PAGE and immunoblotting with FLAG or GFP antibody. T, total 
extract. (C) Rpl26a-HHZ produced in excess poorly assembles into ribosomes. Same as A except 
that a different genotype was used. Cells lacked both natural RPL26 loci and contained an 
integrated copy of constitutively expressed RPL26A-GFP as well as an inducible, plasmid-
encoded copy of RPL26A-HHZ. Immunoblotting was performed using antibodies against GFP 
and HA. T, total extract. Black circle indicates constitutively expressed Rpl26a-GFP, and open 
circle indicates transiently induced Rpl26a-HHZ. Some of the bands have a light-colored center 
that indicates regions where the signal has saturated the detector. (D) Unassembled Rpl26a 
accumulates in the nonribosomal fractions upon proteasome inhibition. Same as A, except that 
50 μM btz was added after the first 30 min of galactose induction. (E) Polyubiquitinated Rpl26a 
accumulates in nonribosomal fractions upon proteasome inhibition. WT cells were treated as in 
D. Sucrose gradient fractions were pooled as shown and incubated with UBA resin to enrich 
ubiquitin conjugates, and the bound fractions were separated by SDS–PAGE and 
immunoblotted with FLAG antibody. Hexokinase was used as an internal control. L.E and S.E, 
long and short exposure, respectively.
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some, we observed robust accumulation of 
many ribosomal proteins in an insoluble 
fraction, and this was suppressed by coinhi-
bition of protein synthesis. Taken together, 
these observations suggest that newly syn-
thesized ribosomal proteins that fail to as-
semble form insoluble aggregates. Of inter-
est, microscopic analysis of overexpressed 
Rpl26-GFP in pre9∆ cells typically revealed 
a focal signal overlaid on a diffuse back-
ground of nuclear staining. This suggests 
that if an unassembled ribosomal protein 
escapes degradation, it assembles into a 
sedimentable aggregate, possibly the re-
cently described intranuclear quality control 
compartment (Miller et al., 2015). Although 
we cannot exclude the possibility that bort-
ezomib itself induces ribosome misassem-
bly, we note that ribosomal proteins are 
among the most prominent ubiquitin-conju-
gated proteins in log-phase yeast cells 
(Mayor et al., 2005, 2007). Similarly, ribo-
somal proteins contain a substantial fraction 
of the ubiquitination sites identified in 
K-ε-GG profiling experiments in both yeast 
(Porras-Yakushi et al., 2015) and human 
(Higgins et al., 2015) cells.
A number of questions remain to be ad-
dressed in future work. Specifically, are ex-
cess ribosomal proteins ubiquitinated in the 
nucleolus and then exported to the nucleo-
plasm for degradation, or are they first re-
leased to the nucleoplasm and then ubiqui-
tinated? Does one ubiquitination pathway 
process all excess ribosomal subunits, or are 
there multiple, possibly even redundant 
pathways? How is it possible that the quality 
control mechanism can correctly identify vir-
tually any unassembled ribosomal protein 
and yet maintain a high degree of specificity 
by ignoring the very same proteins when 
they are correctly assembled? The answers 
to these questions will lift the veil on what 
may be one of the most important, highest-
flux quality control pathways in the cell.
MATERIALS AND METHODS
Yeast strains and growth conditions
All yeast strains used in this study (Supple-
mental Table S1) were derived from BY4741 
(MATa his3∆1 leu2∆0 met15∆0 ura3∆0). 
Yeast transformation was performed by the 
lithium acetate method (Gietz and Schiestl, 
2007). All transformants were verified by auxotrophic selection or ge-
nomic PCR. Yeast was grown at 30°C in yeast extract/peptone/dex-
trose or appropriate synthetic complete (SC) drop-out medium. For 
ectopic expression of proteins from the GAL1 or GAL10 promoter, 
cells grown in raffinose-containing medium were treated with 2% ga-
lactose for 60–90 min. Note that experiments were initiated with cells 
at OD600 = 3.0 because the QC pathway for unassembled ribosomal 
proteins was more prominent in cells at mid log phase (OD600 ≈ 3.0) 
then with early log phase (OD600 ≈ 1.0) (unpublished data).
that there will be modest stoichiometric imbalances in the production 
of ribosomal proteins because there is no known mechanism in eu-
karyotic cells that could enable the production of exactly the same 
number of all 79 ribosomal proteins. In addition, synthesis of defec-
tive, assembly-incompetent proteins (e.g., due to misincorporation 
events in transcription or translation) and errors in the assembly pro-
cess should yield additional QC substrates. These QC events are 
normally not detected because the unassembled proteins are al-
most instantly degraded. However, upon inhibition of the protea-
FIGURE 6: The small steady-state pool of excess Rpl26 resides primarily in the nucleus and 
nucleolus. (A) Induced Rpl26a is enriched in the nucleus. WT and pre9∆ cells were induced with 
galactose for 1 h to express Rpl26a-GFP. Whole cell extract (WCE) was fractionated into cytosolic 
(Cy) and nuclear (Nu) fractions, which were analyzed by SDS–PAGE and immunoblotting with an 
antibody against GFP. Histone H3 and hexokinase were used as nuclear and cytoplasmic 
markers, respectively. (B) Induced Rpl26a accumulates in the nucleus upon treatment with 
proteasome inhibitor. Same as A, except that 50 μM MG132 was added to WT cells after 30 min 
of galactose induction. L.E and S.E, long and short exposure, respectively. (C) Induced Rpl26a in 
pre9∆ cells localizes in the nucleus/nucleolus. WT and pre9∆ cells harboring a NOP56-RFP allele 
to mark nucleoli were induced with galactose for 1 h to express Rpl26a-GFP and analyzed by 
fluorescence microscopy. Arrow indicates the accumulation of Rpl26a in a nonnucleolar region. 
Right, percentage of GFP-positive cells. (D) Induced Rpl26a localizes in the nucleus/nucleolus of 
WT but in the cytoplasm of rpl26a∆rpl26b∆ cells. WT cells harboring a NOP56-RFP allele to mark 
nucleoli and rpl26a∆rpl26b∆ cells were induced with galactose for 1 h to express Rpl26a-GFP 
and analyzed by fluorescence microscopy. Right, percentage of GFP-positive cells.
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Plasmid construction
All plasmids used in this study are listed 
in Supplemental Table S2. To construct 
pESC(HIS)-PGAL10-RPL26A-FLAG (RDB 3124), 
the ∼825–base pair PCR product obtained 
using genomic DNA as a template, forward 
primer 5′-CAG TCG AAT TCA TGG CTA AAC 
AAT CAT TAG GTA TGT GCA CAA ATG CTA 
AAT-3′, and reverse primer 5′-GTC AGC 
GGC CGC TTC CAA CTT ACC GCC CTT 
TCT TTG GAT CAA AGC TTT TCT G-3′ 
was digested with EcoRI and NotI and li-
gated into EcoRI–NotI-digested pESC(HIS) 
(Agilent Technologies, Santa Clara, CA), thus 
generating pESC(HIS)-PGAL10-RPL26A-FLAG.
To construct pESC(HIS)-PGAL10-RPL26A-
GFP (RDB 3125), the ∼715–base pair PCR 
product obtained using pFA6a-GFP-
His3MX6 (Longtine et al., 1998) as a tem-
plate, forward primer 5′-ATT CAT GAT CGA 
TCA GTA AAG GAG AAG AAC TTT-3′, 
and reverse primer 5′-CAG TCT TAA TTA 
ACT ATT TGT ATA GTT CAT CCA-3′ was 
digested with ClaI and PacI and ligated 
into ClaI–PacI-digested pESC(HIS)-PGAL10-
RPL26A-FLAG, generating pESC(HIS)-
PGAL10-RPL26A-GFP by replacing the FLAG 
tag with the GFP coding sequence.
Subcellular fractionation of yeast cells
Subcellular fractionation was performed 
as described (Keogh et al., 2006). One hun-
dred OD600 units of cells grown in rich 
medium (OD600 ≤ 1.0) were collected by 
centrifugation and then treated with 200 U of 
Zymolyase for 1 h at 30°C in 1 ml of SB buffer 
(1 M sorbitol, 20 mM Tris-HCl, pH 7.5, 10 mM 
β-mercaptoethanol). Spheroplasts collected 
by centrifugation (2000 rpm for 5 min at 4°C) 
were washed twice with SB buffer and then 
resuspended in 500 μl of EBX buffer (20 mM 
Tris-HCl, pH 7.5, 100 mM NaCl, 0.25% Triton 
X-100, 15 mM β-mercaptoethanol, and pro-
tease inhibitor cocktail [EDTA-free; Roche, 
Basel, Switzerland]). An aliquot was taken 
and used as a total cell extract, and the re-
mainder of the lysate was layered over 1 ml 
of NIB buffer (20 mM Tris-HCl, pH 7.5, 
100 mM NaCl, 1.2 M sucrose, 15 mM β-
mercaptoethanol, and protease inhibitor 
cocktail [EDTA-free; Roche]) and centrifuged 
(12,000 rpm for 15 min at 4°C in an Eppen-
dorf Centrifuge 5430R). A sample of the up-
per soluble fraction was taken and used as 
cytosol and the rest of the supernatant dis-
carded. The glassy white nuclear pellet was 
suspended in 500 μl of EBX buffer and kept 
on ice for 10 min with gentle mixing, and an 
aliquot was taken and used as the nuclear 
fraction. A 2× SDS–PAGE loading buffer was 
added to each fraction, and samples were 
FIGURE 7: Newly synthesized endogenous ribosomal proteins aggregate in proteasome 
inhibitor–treated cells. (A) Unassembled endogenous ribosomal proteins aggregate in cells 
treated with proteasome inhibitor. Cells were treated with 50 μM btz for 1 h. Whole-cell extract 
(WCE) was fractionated into soluble and pellet fractions, which were analyzed by SDS–PAGE 
followed by Coomassie blue staining (left) or immunoblotting with antibodies against ubiquitin 
and the indicated ribosomal proteins (right). Hexokinase was used as an internal control. 
(B) Scatter plot representing ∆iBAQ of biological replicate B vs. A for aggregated proteins in 
btz-treated cells. Proteins are color-coded as indicated. Ribosomal proteins with the largest 
increase in the pellet fraction upon proteasome inhibition and Rpl3 and Rps2 are annotated. 
Pearson’s r is indicated on the top of the plot. BTZ, btz-treated cells; NC, nontreated cells. 
(C) Gene ontology analysis of aggregated proteins upon proteasome inhibition. Violin plot 
representing the distribution of ∆iBAQ for all proteins (blue) and the two most strongly 
affected categories: proteins related to mitochondrion (green) and ribosomal proteins (red). 
The number in parentheses below each category refers to the disproportionate enrichment 
for the category in the top 10% of identifications. This is the Benjamini–Hochberg corrected 
p value from a Fisher exact test. (D) The 20 proteins with the largest increase in the pellet 
fraction upon proteasome inhibition. Values are the average difference of iBAQ between 
btz-treated and nontreated samples, with error bars indicating SEM. Blue, red, and gray bars 
correspond to 60S, 40S, and nonribosomal proteins, respectively. (E) Newly synthesized 
endogenous ribosomal proteins aggregate in cells treated with proteasome inhibitor. Same as 
A except that cells were pretreated with 50 μg/ml cycloheximide (CHX) for 30 min before 
addition of btz.
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Sucrose gradient and polysome profiling
Sucrose gradient and polysome profiling were performed as de-
scribed (Verma et al., 2013). Yeast cells were grown to logarithmic 
phase in rich medium supplemented with glucose or raffinose at 
30°C and treated with cycloheximide (100 μg/ml) for 15 min before 
cell lysis to stabilize polysomes. One hundred OD600 units of cells 
were harvested and disrupted by bead beating in lysis buffer (0.5 mM 
dithiothreitol [DTT], 100 μg/ml cycloheximide, 200 μg/ml heparin, 
20 mM Tris-HCl, pH 7.5, 140 mM KCl, 5 mM MgCl2, and protease 
inhibitor cocktail [EDTA-free; Roche]). Cell debris was removed by 
centrifuging at 3000 rpm for 5 min, and the remaining cell extract 
was centrifuged at 12,000 rpm for 10 min in an Eppendorf Centri-
fuge 5430R. Twenty-five A260 units of cell lysate layered on 7–47% 
discontinuous sucrose gradient prepared in buffer (1 mM DTT, 
140 mM KCl, 20 mM Tris-HCl, pH 7.5, and 5 mM MgCl2) were cen-
trifuged in SW55Ti rotor for 90 min at 50,000 rpm. For polysome 
profiling analysis, we fractionated samples while continuously re-
cording the absorbance at 254 nm with an ultraviolet detector (ISCO, 
Lincoln, NE). For Western blot, 0.2-ml fractions collected from the 
top were treated with 0.02% sodium deoxycholate for 30 min on ice 
and then precipitated by adding trichloroacetic acid to 10% final 
concentration for 1 h. Pellets were washed with ice-cold acetone and 
then resuspended in 2× SDS-containing sample buffer.
Isolation of protein aggregates
Isolation of protein aggregates from yeast cells was performed as 
described previously (Koplin et al., 2010) with slight modifications. 
One hundred OD600 units of exponentially growing cells in an ap-
propriate medium were harvested, and cell pellets were frozen in 
liquid N2. The cell pellets were resuspended in 1 ml lysis buffer 
(20 mM Na phosphate, pH 6.8, 10 mM DTT, 1 mM EDTA, 0.1% 
Tween, 1 mM phenylmethylsulfonyl fluoride [PMSF], protease inhibi-
tor cocktail, and 100 U/ml Zymolyase) and incubated at 30°C for 
30 min. Chilled samples were treated by tip sonication (20%, 10 s, 
twice) and centrifuged for 20 min at 600 × g at 4°C. Supernatants 
were adjusted to identical protein concentrations, and aggregated 
proteins were pelleted at 16,000 × g for 20 min at 4°C. After re-
moval of supernatants, aggregated proteins were washed once with 
wash I buffer (20 mM Na phosphate, pH 6.8, 500 mM NaCl, 5 mM 
EDTA, 2% NP-40, 1 mM PMSF, and protease inhibitor cocktail) and 
centrifuged at 16,000 × g for 20 min at 4°C. Aggregated proteins 
were washed twice with wash II buffer (20 mM Na phosphate, 
pH 6.8) and sonicated (10%, 10 s, twice) in 40 μl of wash II buffer. A 
10-μl amount of SDS sample buffer was added to aggregate sam-
ples, and proteins are separated by SDS–PAGE (4–20%), and ana-
lyzed by Coomassie blue staining and immunoblotting.
Binding to UBA columns and Usp2 treatment
Immunoprecipitation of ubiquitin conjugates was performed as de-
scribed, with some modifications (Verma et al., 2013). TUBE2-UBA 
resin (AM-130; Boston Biochem, Cambridge, MA) was used to bind 
polyubiquitinated substrates. One hundred OD600 units of cells 
were harvested and disrupted by bead beating in 500 μl of lysis buf-
fer (20 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1 mM EDTA, 10% glyc-
erol, 5 mM N-ethylmaleimide [NEM], 1% Triton X-100, and protease 
inhibitor cocktail [EDTA-free; Roche]). Cell debris was removed by 
centrifuging at 3000 rpm for 5 min, and the remaining cell extract 
was centrifuged at 12,000 rpm for 10 min in an Eppendorf Centri-
fuge 5430R. A 30-μl amount of TUBE2-UBA resin incubated over-
night was washed three times with buffer (20 mM Tris-HCl, pH 8.0, 
150 mM NaCl, 0.5% Triton X-100). A 50-μl 2× SDS-containing sam-
ple buffer was added to the resin and boiled for 5 min. Note that 
incubated at 95°C for 5 min and then subjected to SDS–PAGE and 
Western analyses.
Microscopic analysis
Yeast cells grown in raffinose-containing SC medium at 30°C (OD600 
≤ 1.0) were induced with galactose for 1 h to express Rpl26a-
GFP and placed in 384-well glass-bottom microplates (Whatman, 
Maidstone, UK) pretreated with concanavalin A (L7647; Sigma-Al-
drich, St. Louis, MO) to ensure cell adhesion. Fluorescence images 
were taken using a Zeiss Axiovert 200M Inverted Microscope with a 
fluorescein isothiocyanate filter set (excitation band pass filter, 450–
490 nm; beam splitter, 510 nm; emission band pass filter, 515–565 
nm) and a rhodamine filter set (excitation band pass filter, 546 nm; 
beam splitter, 580 nm; emission long pass filter, 590 nm). We ana-
lyzed at least 50 cells and reconfirmed subcellular localization of 
GFP-fused proteins by colocalization assay as described previously 
(Huh et al., 2003).
Preparation of samples for immunoblotting
For denatured samples, yeast cells were harvested, washed two 
times with phosphate-buffered saline, and boiled in 2× SDS-con-
taining sample buffer for 5 min, followed by brief bead beating. For 
nondenatured samples, yeast cells were harvested and disrupted by 
bead beating in lysis buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 
1% Triton X-100, and protease inhibitor cocktail [EDTA-free; Roche]). 
Cell debris was removed by centrifuging at 3000 rpm for 5 min, and 
the remaining cell extract was centrifuged at 12,000 rpm for 10 min 
in an Eppendorf Centrifuge 5430R. After centrifugation, the super-
natant was transferred to a new tube and mixed with SDS–PAGE 
sample buffer.
Antibodies
Anti-Rpl3 and anti-Rpl30/Rps2 were generous gifts from Jonathan 
Warner (Albert Einstein College of Medicine). Anti-GFP (632375; 
1:10,000 dilution) was from Clontech (Mountain View, CA), anti-
FLAG (F1804; 1:10,000 dilution) was from Sigma-Aldrich, anti-hexo-
kinase (H2035-02; 1:10,000 dilution) was from USBiological (Salem, 
MA), anti–histone H3 (ab1791; 1:5000 dilution) was from Abcam 
(Cambridge, UK), anti-HA (SC-7392; 1:5000 dilution) was from Santa 
Cruz Biotechnology (Dallas, TX), and anti-ubiquitin (05-944; 1:5000 
dilution) was from EMD Millipore (Temecula, CA). For secondary an-
tibody, horseradish peroxidase (HRP)–conjugated anti-rabbit immu-
noglobulin G (IgG; A6154; 1:10,000 dilution) and HRP-conjugated 
anti-mouse IgG (M8770; 1:10,000 dilution) were from Sigma-
Aldrich, and IR680RD-conjugated anti-rabbit (926-68071; 1:10,000 
dilution) and IR800CW-conjugated anti-mouse (926-32210; 
1:10,000 dilution) were from LI-COR Biotechnology (Lincoln, NE).
Quantification of RPL26A mRNA
Total RNA was isolated from yeast cells using TRIzol (15596-026; 
Invitrogen, Carlsbad, CA). cDNA for reverse transcription (RT)-PCR 
was generated using the Reverse Transcription System (A3500; 
Promega, Madison, WI). The amounts of RPL26A and ACT1 mRNA 
were analyzed by quantitative real-time RT-PCR using the Applied 
Biosystems StepOnePlus Real-Time PCR System. Amplification effi-
ciencies were validated and normalized against ACT1, and fold in-
creases were calculated using the 2−∆∆CT method (Livak and Schmitt-
gen, 2001). The primers used for the amplification of RPL26A were 
5′-TCC AAG AAG GGT CAA GAA GG-3′ and 5′-GGA TCA AAG CTT 
TTC TGT CC-3′, and those used for ACT1 were 5′ TGA CTG ACT 
ACT TGA TGA AG-3′ and 5′-TGC ATT TCT TGT TCG AAG TC-3′. All 
reactions were carried out in triplicate.
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unmodified proteins can also potentially bind due to indirect inter-
actions with ubiquitinated proteins. For Usp2 treatment, TUBE2-
UBA resin prepared as described was washed twice with 1× ubiqui-
tin reaction buffer (50 mM Tris-HCl, pH 8.0, 10 mM MgCl2, 0.2 mM 
CaCl2, and 1 mM DTT) and mixed with 1 μM Usp2 (E-504; Boston-
Biochem) at 30°C for 1 h.
Mass spectrometry analyses of protein aggregates
Insoluble protein pellets were solubilized in an 8 M urea buffer (40 
mM Tris, 65 mM DTT, 100 mM ammonium bicarbonate) containing 
cOmplete Protease Inhibitor Cocktail (Roche) and sonicated for 10 s 
at 10% of maximum amplitude using a Branson Digital Sonifier. Sam-
ples were digested and prepared for mass spectrometry as described 
in Pierce et al. (2013). A 150-ng amount of digested peptides from 
btz-treated cells and an equal volume of peptides from untreated 
cells were analyzed using an EASY-nLC 1000 coupled to an Orbitrap 
Fusion. Spectra were analyzed by MaxQuant (version 1.5.3.30). 
Digested peptides were loaded onto a 26-cm analytical HPLC col-
umn (75 μm inner diameter) packed in-house with ReproSil-Pur 
C18AQ 1.9-μm resin (120-Å pore size; Dr. Maisch, Ammerbuch, 
Germany). After loading, the peptides were separated with a 120-min 
gradient at a flow rate of 350 nl/min at 50°C (column heater) using 
the following gradient: 2–6% solvent B (7.5 min), 6–25% B (82.5 min), 
25–40% B (30 min), 40–100% B (1 min), and 100% B (9 min), where 
solvent A was 97.8% H2O, 2% ACN, and 0.2% formic acid, and 
solvent B was 19.8% H2O, 80% ACN, and 0.2% formic acid. The 
Orbitrap Fusion was operated in data-dependent acquisition mode 
to automatically switch between a full scan (m/z = 350–1500) in the 
Orbitrap at 120,000 resolving power and an MS/MS scan of higher-
energy collisional dissociation fragmentation detected in the ion trap 
(using TopSpeed). The automatic gain control (AGC) targets of the 
Orbitrap and ion trap were 400,000 and 10,000, respectively.
Data analysis
Raw data were searched using MaxQuant (version 1.5.3.30; Cox and 
Mann, 2008; Wagner et al., 2011) against the Saccharomyces 
Genome Database (SGD) (5911 entries) and a contaminant database 
(259 entries). Precursor mass tolerance was 4.5 ppm after automatic 
recalibration. Fragment ion tolerance was 0.5 Da. Trypsin was 
specified as the digestion enzyme with up to two missed cleavages 
allowed. Oxidation of methionine and protein N-terminal acetylation 
were specified as variable modifications, and carbamidomethylation 
of cysteine was specified as a fixed modification. iBAQ protein quan-
titation and “match between runs” were enabled. Protein and 
peptide false discovery rates were estimated to be <1% using a tar-
get-decoy approach.
For each pair of btz-treated and nontreated (NC) samples, the 
difference between iBAQ abundances (∆iBAQ) was used to identify 
the proteins that were most accumulated in the insoluble fraction 
after treatment with btz. The average difference between btz-
treated and NC samples across the three replicates was then used 
to identify the top 10% of proteins most accumulating. This set of 
127 proteins was checked for annotation enrichment against all pro-
teins identified in the sample using DAVID (Huang et al., 2009a,b). 
The most enriched terms included GO FAT cellular component an-
notations “ribosome” (p < 2E-9) and “mitochondrion” (p < 2E-5). 
The distribution of average ∆iBAQ values for all proteins and for 
proteins with those annotations is given in Figure 7C. The individual 
ribosomal protein ∆iBAQ values are displayed in Supplemental 
Figure S3C, with error bars indicating SEM. Distributions of average 
∆iBAQ values for large and small ribosomal subunits are compared 
with nonribosomal proteins in Supplemental Figure S3D.
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